STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 609 participants.
Also called NCT02777580
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 609 participants
- Sponsor
- Registry
-
NCT02777580
-
- Other papers using this trial's data
- STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Australia, Brazil, Canada, Chile, France, Mexico, Montenegro, Russia, Serbia, Spain
- Registry status
- Completed
Technical summary
Registry record NCT02777580. Randomized; no masking; primary purpose treatment. Start 2017-08-01 (actual); primary completion 2022-10-13 (actual). Results posted on 2024-10-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction
- Acronym
- STREAM-2
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Tenecteplase
- Intervention (Drug)
- Clopidogrel
- Intervention (Procedure)
- Coronary angiography
- Intervention (Procedure)
- Primary PCI (percutaneous coronary intervention)
- Lead sponsor
- KU Leuven
- Collaborator
- Boehringer Ingelheim
- Collaborator
- Life Sciences Research Partners
- Collaborator
- Frans Van de Werf Fund for Clinical Cardiovascular Research
Record details
- Record id
cardio:ct-nct02777580- Content hash
f9c8fcd33045cf84566671aa6d51d91850dade8999e0afbd95762eb0169ad4d1